Search company, investor...

Compare Milestone Pharmaceuticals vs WaferGen Bio-systems

Customers evaluate the quality of Milestone Pharmaceuticals's products using the following success metrics.

Overview

Milestone Pharmaceuticals is 21 yrs old and is based in Canada.

Milestone Pharmaceuticals (Nasdaq: MIST) is a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. Etripamil is a potent and short-acting calcium channel blocker designed by Milestone and being developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of PSVT as they occur.

WaferGen Bio-systems is 22 yrs old and is based in United States.

WaferGen markets SmartChip TE (Target Enrichment for Next-Generation Sequencing (NGS)) and SmartChip MyDesign (high-throughput quantitative PCR) products. SmartChip TE addresses CLIA-certified and clinical research laboratories' significant unmet needs in sequencing-based testing by providing uniform coverage of targeted genes, yielding better test specificity and sensitivity. The superior performance of this new product is based on WaferGen's proprietary technology that relies on massively parallel singleplex PCR reactions, where amplification is cleaner and better controlled, thereby providing more accurate diagnostic test results in the downstream sequencing step. On the qPCR side, the SmartChip MyDesign System has a powerful value proposition of content design flexibility, cost-effectiveness, and no need for pre-amplification.

Demo Video

Demo not available because Milestone Pharmaceuticals has not claimed their profile.

Work for Milestone Pharmaceuticals? Show off your product.

Demo not available because WaferGen Bio-systems has not claimed their profile.

Work for WaferGen Bio-systems? Show off your product.

Leadership

Amjad Huda (Chief Financial Officer)

See all 5 people

Funding

Milestone Pharmaceuticals last raised $82.5M on 5/9/2019.

Investors

Fonds de Solidarite FTQ, Go Capital

See all 5 investors

Takara Bio, Yorkville Advisors

See all 5 investors

Product

Benefits

Products

Customers

Known Partners

Why They Buy

Information not available because Milestone Pharmaceuticals has not claimed their profile.

Work for Milestone Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for Milestone Pharmaceuticals?

Claim your profile now.

Information not available because WaferGen Bio-systems has not claimed their profile.

Work for WaferGen Bio-systems? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for WaferGen Bio-systems?

Claim your profile now.